Porous silicon and silica carriers for delivery of peptide therapeutics

Jiachen Yan,Prakriti Siwakoti,Siuli Shaw,Sudeep Bose,Ganesh Kokil,Tushar Kumeria

DOI: https://doi.org/10.1007/s13346-024-01609-7

2024-06-01

Drug Delivery and Translational Research

Abstract:Peptides have gained tremendous popularity as biological therapeutic agents in recent years due to their favourable specificity, diversity of targets, well-established screening methods, ease of production, and lower cost. However, their poor physiological and storage stability, pharmacokinetics, and fast clearance have limited their clinical translation. Novel nanocarrier-based strategies have shown promise in overcoming these issues. In this direction, porous silicon (pSi) and mesoporous silica nanoparticles (MSNs) have been widely explored as potential carriers for the delivery of peptide therapeutics. These materials possess several advantages, including large surface areas, tunable pore sizes, and adjustable pore architectures, which make them attractive carriers for peptide delivery systems. In this review, we cover pSi and MSNs as drug carriers focusing on their use in peptide delivery. The review provides a brief overview of their fabrication, surface modification, and interesting properties that make them ideal peptide drug carriers. The review provides a systematic account of various studies that have utilised these unique porous carriers for peptide delivery describing significant in vitro and in vivo results. We have also provided a critical comparison of the two carriers in terms of their physicochemical properties and short-term and long-term biocompatibility. Lastly, we have concluded the review with our opinion of this field and identified key areas for future research for clinical translation of pSi and MSN-based peptide therapeutic formulations.

pharmacology & pharmacy,medicine, research & experimental

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are the limitations of peptide drugs in physiological and storage stability, pharmacokinetics, and rapid clearance, which limit the clinical applications of peptide drugs. To overcome these problems, researchers have explored new nano - carrier strategies, especially porous silicon (pSi) and mesoporous silica nanoparticles (MSNs) as potential carriers for peptide drug delivery. These materials, due to their large specific surface area, adjustable pore diameter and pore structure, etc., become ideal peptide drug carriers. The paper reviews the applications of pSi and MSNs in peptide drug delivery, including their preparation, surface modification and unique properties, and systematically reviews various studies on peptide drug delivery using these porous carriers, and describes important in - vitro and in - vivo results. In addition, the paper also makes a critical comparison between these two carriers in terms of physical and chemical properties and short - term and long - term biocompatibility, and makes suggestions for future research directions, aiming to promote the clinical translation of pSi - and MSN - based peptide drug formulations.